In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
As of close of business last night, Cg Oncology Inc’s stock clocked out at $24.85, up 2.05% from its previous closing price of $24.35. In other words, the price has increased by $2.05 from its previous closing price. On the day, 0.67 million shares were traded. CGON stock price reached its highest trading level at $25.07 during the session, while it also had its lowest trading level at $24.0713.
Ratios:
To gain a deeper understanding of CGON’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 22.15 and its Current Ratio is at 22.15. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On May 02, 2025, JP Morgan started tracking the stock assigning a Overweight rating and target price of $41.
On April 16, 2025, Scotiabank started tracking the stock assigning a Sector Perform rating and target price of $23.Scotiabank initiated its Sector Perform rating on April 16, 2025, with a $23 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jul 17 ’25 when POST LEONARD E sold 2,000 shares for $28.00 per share. The transaction valued at 56,000 led to the insider holds 0 shares of the business.
LEONARD E POST bought 2,000 shares of CGON for $52,160 on Jul 17 ’25. On May 21 ’25, another insider, POST LEONARD E, who serves as the Director of the company, sold 1,000 shares for $28.00 each. As a result, the insider received 28,000 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CGON now has a Market Capitalization of 1894198656 and an Enterprise Value of 1234694400. For the stock, the TTM Price-to-Sale (P/S) ratio is 3444.00 while its Price-to-Book (P/B) ratio in mrq is 2.83. Its current Enterprise Value per Revenue stands at 2240.825 whereas that against EBITDA is -7.86.
Stock Price History:
The Beta on a monthly basis for CGON is 0.89, which has changed by -0.24468082 over the last 52 weeks, in comparison to a change of 0.19554341 over the same period for the S&P500. Over the past 52 weeks, CGON has reached a high of $40.47, while it has fallen to a 52-week low of $14.80. The 50-Day Moving Average of the stock is -5.40%, while the 200-Day Moving Average is calculated to be -11.27%.
Shares Statistics:
It appears that CGON traded 930.78K shares on average per day over the past three months and 861610 shares per day over the past ten days. A total of 76.23M shares are outstanding, with a floating share count of 44.88M. Insiders hold about 41.12% of the company’s shares, while institutions hold 69.17% stake in the company. Shares short for CGON as of 1752537600 were 10782077 with a Short Ratio of 11.58, compared to 1749772800 on 11077034. Therefore, it implies a Short% of Shares Outstanding of 10782077 and a Short% of Float of 14.979999999999999.
